iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy

Investigators used a combination of induced pluripotent stem cell (iPSC)-based disease modeling and CRISPR/Cas9-mediated genome editing to generate patient-specific cardiomyocytes and isogenic controls lacking the pathogenic MYBPC3 variant.